

This Viewpoint issues a multidisciplinary call to embed sustainability into anticoagulation care, aligning clinical excellence with climate responsibility. Anticoagulation management—including drug manufacturing, laboratory diagnostics, therapeutic monitoring, and long-term follow-up—contributes substantially to health-care-associated carbon emissions. We propose a systems-level decarbonisation strategy, anchored in life cycle assessment methodology, to quantify emissions across anticoagulation care and identify high-impact intervention points.
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet
Haematology
|15th Jan, 2026
|The Lancet